TME Pharma announces strategic plan to externalize and monetize second clinical stage asset NOX-E36
. NOX-E36 presents promising opportunity for development in eye diseases with a high need for well-tolerated therapies…
. NOX-E36 presents promising opportunity for development in eye diseases with a high need for well-tolerated therapies…
NurExone Biologic Inc. (TSXV: NRX), (OTCQB: NRXBF), (Deutschland: J90) (das „Unternehmen“ oder „NurExone“), ein biopharm…
The global medical laser market size is expected to be worth around US$ 15.63 billion by 2030 and is poised to record a…
. Purpose-built bioconjugation facility in Lonza’s Ibex® Dedicate Biopark in Visp, Switzerland to support the potentia…
According to Future Market Insights (FMI), the demand for ocular drug delivery system is expected to rise considerably,…
ESOMAR-certified consulting firm Future Market Insights’ report, projects a healthy growth, for optical coherence tomogr…
Die Studie enthält Informationen zur aktuellen Marktgröße des globalen Ocular Drug Delivery-Technologie Marktes sowie Wa…
Global Pyrazosulfuron Ethyl Cas Market Analysis (2021-2031) Featuring Fastest Growing Companies: abcr GmbH, Finetech Ind…
Dopavision, a company pioneering the development of digital therapeutics, today announced the closing of a €12 million S…
. Transparency Market Research (TMR) has published a new report on the corneal topographers market for the forecast peri…